SLQT Earnings

SLQT reported its earnings on 2026-05-05, showcasing a revenue of 430.93M against an estimate of 449.00M, resulting in a -4.02% surprise. The EPS was 0.15, surpassing the expected -0.02 by 850%. The stock experienced a 52.43% price change on the earnings day and a 37.68% change over the next five days, reflecting market reactions to the results.

Following SLQT's earnings announcement on 2026-05-05, the stock price moved by 52.43% on the day of the release. Over the subsequent five days, it saw a 37.68% change. Historically, SLQT's stock price tends to shift by an average of 17.88% in the 10 days leading up to earnings and -5.6% in the 10 days following, providing insight into potential market.

For 2026/Q4, analysts estimate SLQT's annual revenue to reach 370.63M, while the EPS is projected at -0.12. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between SLQT's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2026 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, SLQT's stock price typically moves by 17.88% in the 10 days before its earnings and -5.6% in the 10 days after. For the upcoming 2026/Q4 earnings, analysts expect an EPS of -0.12 and revenue of 370.63M.

The earnings call reflects mixed signals: stable PBM reimbursement and positive Medicare Advantage outlook are balanced by IRA-induced revenue decline and cautious guidance. The Q&A reveals management confidence in achieving EBITDA targets and operational efficiencies, yet lacks detailed metrics on valuation concerns. Flat membership growth and guidance adjustments suggest limited short-term stock movement. Without market cap data, a neutral prediction is prudent.